Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencingCornelius Kürten, Robert L. Ferris, Aditi Kulkarni et al.|Nature Communications|2021Cited by 303
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapiesHousaiyin Li, Robert L. Ferris, Seungwon Kim et al.|Cancer Cell|2025Cited by 64
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck CancerDan P. Zandberg, Julie E. Bauman, Lazar Vujanović et al.|Journal of Clinical Oncology|2025Cited by 20
Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).Robert L. Ferris, Dan P. Zandberg, William E. Gooding et al.|Journal of Clinical Oncology|2023Cited by 17
683 CD8 T cell repertoire analysis of patients with resectable head and neck cancer enrolled in a phase II neoadjuvant study of α-PD1 administered alone or in combination with α-CTLA4 or α-LAG3Patrícia Santos, Robert L. Ferris, Aditi Kulkarni et al.|Regular and Young Investigator Award Abstracts|2022Cited by 2